Transport of cellular and neuronal vesicles, organelles, and other particles along microtubules requires the molecular motor protein dynein (Mallik and Gross, 2004) . Critical to dynein function is dynactin, a multi-protein complex commonly thought to be required for dynein attachment to membrane compartments (Karki and Holzbaur, 1999) . Recent work has also found that mutations in dynactin can cause the human motor neuron disease, ALS (Puls et al., 2003) . Thus, it is essential to understand the in vivo function of dynactin. To test directly and rigorously the hypothesis that dynactin is required to attach dynein to membranes, we used both a Drosophila mutant and RNA interference to generate organisms and cells lacking the critical dynactin subunit Arp1. Contrary to expectation, we found that apparently normal amounts of dynein associate with membrane compartments in the absence of a fully assembled dynactin complex. In addition, anterograde and retrograde organelle movement in dynactin deficient axons was completely disrupted, resulting in substantial changes in vesicle kinematic properties.
Introduction
Dynein is the major molecular motor protein responsible for a wide variety of microtubulebased minus-end directed movements of vesicles and organelles, as well as several steps in mitosis (Mallik and Gross, 2004) (Karki and Holzbaur, 1999) (Pilling et al., 2006) . A key gap in our understanding of dynein function is how this motor protein interacts with membrane compartments. One candidate factor proposed to link dynein to membrane compartments is a multi-protein complex called dynactin (reviewed in (Schroer, 2004) . Although the original work on dynactin suggested that highly purified dynein could mediate vesicle attachment to microtubules in the absence of dynactin, a more recent, and relatively small number of in vitro experiments have led to the generally accepted model that the attachment of dynein to membrane vesicles requires dynactin (Muresan et al., 2001 ) (Waterman-Storer et al., 1997) (Karki and Holzbaur, 1999 ). An alternative model suggests that dynein light and intermediate chain subunits may link dynein to other membrane-associated proteins independent of dynactin (Tai et al., 1999) (Yano et al., 2001 ) (Tynan et al., 2000) . In this competing view, dynactin plays a role in regulating or coordinating dynein functions such as processivity (King and Schroer, 2000) .
Understanding the role of dynactin in dynein function has recently become more important with the realization that these proteins may be targets in human neurodegenerative diseases (Puls et al., 2003) (Hafezparast et al., 2003) . Yet, in spite of the importance of this issue, definitive evidence on the in vivo role of dynactin in dynein attachment to membranes does not exist and no direct experiment testing whether dynactin is required for linking dynein to membranes in vivo has been reported.
The actin-related protein Arp1 is the most abundant subunit of the dynactin multi-protein complex. This 45kD protein forms a filament composed of 8 to 13 monomers, which is capped 3 by the p37 and p32 capping proteins on one end (also known as CapZ) and the p62 subunit of dynactin on the other end. These proteins in addition to some smaller subunits, such as p25, p27
and Arp11 form a scaffold upon which p150
Glued binds to the Arp1 filament through an interaction mediated by another protein called dynamitin (reviewed in (Schroer, 2004) . Dynein interacts with the dynactin complex via binding of the dynein intermediate chain to the p150 Glued subunit of dynactin (Karki and Holzbaur, 1995) (Vaughan and Vallee, 1995) . Disruption of dynactin functions leads to phenotypes that closely mimic those observed in dynein heavy chain (DHC) and dynein light chain mutants and in antibody inhibition studies (Karki and Holzbaur, 1999) . These data suggest that dynein and dynactin work together to carry out dynein functions although they leave unresolved the question of how dynactin function is required for dynein activity. To elucidate the function of dynactin and to test directly whether dynactin is required to attach dynein to membranes in vivo, we analyzed arp1 mutations and arp1 RNA interference in
Drosophila.

Materials and Methods
Identification and mapping of arp1 mutants.
Homozygous lethal ethyl methanesulfonate (EMS) mutant lines were obtained from the laboratory of Dr. Charles Zuker (University of California, San Diego). The mutant third instar larvae were examined for sluggish crawling and tail flip phenotypes. The arp 1 mutants (previously called gridlock) were mapped to cytological position 87C on the third chromosome of Drosophila by deficiency mapping and meiotic recombination. This region includes the arp1 gene. Genomic arp1 DNA was sequenced from homozygous third instar larvae.
Immunostaining
Larval segmental nerve immunostaining was performed as described previously (Hurd and Saxton, 1996) and observed using a Bio-Rad MRC1024 confocal microscope (Gindhart et al., 1998) .
Antibodies
Anti-dynein heavy chain antibody (P1H4) (a generous gift from Tom Hays), anti-p150 Glued (a generous gift from Erika Holzbaur), anti-p50 (gift from Jason Duncan), anti-syntaxin (8C3) (Hybridoma Bank), anti-KHC (Cytoskeleton), anti-Rab8 and cyt c (BD Transduction Labs), antitubulin and anti-actin (Sigma), anti-DIC (Chemicon), anti-d120 (Calbiochem) were used as described.
Arp1 fusion protein and antibody preparation
7 Arp1 EST clones were found in the Berkeley Drosophila Genome Project database. Only one contained a complete Arp1 cDNA (clone GH17B). This clone was purchased from Research Genetics, fully sequenced, and then subcloned into the pET-23b vector (Novagen), which includes a 6x His tag at the C terminus. The expressed fusion protein was purified using Ni-NTA Agarose resins (Qiagen), electrophoretically isolated, and used to raise antisera in rabbits;
(Lampire Biological Labratories). The specificity of the Drosophila Arp1 antibody was confirmed by Western blotting: a 1:10,000 dilution of the serum detected 5ng of the recombinant protein and also detected Arp1 in 10µg total protein from larval brain extracts. We concluded that the Arp1 antibody cross-reacts with actin, based on the observation that reduction of Arp1 reactivity following arp1 dsRNA treatment is not obvious in the high-speed supernatant where actin is abundant while reduction of Arp1 in the high-speed pellet fraction where no actin can be detected is obvious (Figure 2A ). In addition, sucrose density sedimentation analyses of highspeed supernatants showed a peak at ~8S with sedimentation behavior that is identical to actin in both GFP dsRNA and arp1 dsRNA treated S2 cells (see Figure 2C and D). This peak is not observed in the high-speed pellet fraction where no actin can be detected ( Figure 2E and 2F).
S2 cell culture
S2 cells were grown and maintained in Schneider's Drosophila Medium (Gibco) /10% FBS at room temperature. dsRNA was generated using the Ambion Megascript RNAi Kit from a 500 bp PCR product by using primers that contain the T7 RNP sequence on the end (Eaton et al., 2002) .
The dsRNA (25μg) was added to 2x10 6 cells in a 6-well plate in 1ml of serum free media. After 30 min, 3ml of complete medium was added to each well. Cells were harvested for analysis after 5 days. For reverse transcriptase quantitative PCR (RT-qPCR), total RNA from S2 cells was prepared using the RNeasy Kit (Qiagen). The RNA was subsequently treated with DNAse1 arp1 mRNA was determined by normalizing to a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) control. Primers used for arp1: forward tccgaactgaagaaacactcg and reverse ctgtccctcctcctcgtattc, for GAPDH forward aattaaggccaaggttcagga and reverse accaagagatcagcttcacga.
Sucrose density gradient
For sucrose density gradient analysis of Drosophila larval brains, 250 arp1 1 larval brains and 80
wild-type brains were dissected and homogenized in PMEG buffer (0.1 M Pipes, PH 6.9, 5mM EGTA, 0.9M glycerol, 5mM MgSO 4 , 0.1mM EDTA, 0.5mM DTT and protease inhibitors (Hays et al., 1994) . The high speed supernatant was prepared by centrifugation at 50,000 rpm for 40 min in a Beckman TLA100.3 rotor, then overlaid on a continuous 5%-20% sucrose gradient and centrifuged at 35,000 rpm for 16 h in a Beckman SW41 rotor. For sucrose density gradient analysis of S2 cells, arp1 dsRNA treated cells and GFP dsRNA treated cells were homogenized in buffer A (50mM Tris, 150mM NaCl, pH 7.4, 0.5mM EDTA) plus protease inhibitors, centrifuged sequentially 10 min at 1000xg, 10 min at 10'000xg and 50 min at 100'000xg. The high speed supernatant (HSS) was collected and the high speed pellet (HSP) was resuspended in buffer A + 1% Triton X-100. HSS and HSP were overlaid on a continuous 5%-20% sucrose gradient prepared in buffer A and centrifuged at 35,000rpm for 16 h in a Beckman SW41 rotor. 
Real time movies and quantification.
APP was C-terminally tagged with YFP and expressed under GAL4/UAS control using the P(Gal4)SG26.1 line (Gunawardena et al., 2003) (Kaether et al., 2000) . Crosses were made and 8
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Results and Discussion
Two arp1 mutations were identified in a genetic screen for mutations that disrupt axonal transport in Drosophila melanogaster larvae (Bowman et al., 2000 ) (Bowman et al., 1999) . The arp1 mutants, like other known motor and motor-receptor mutants exhibited a posterior larval paralysis phenotype ( Figure 1A ,B) often accompanied by an upward tail flip during crawling (Hurd and Saxton, 1996) (Martin et al., 1999 ) (Bowman et al., 1999 ) (Bowman et al., 2000) . We amplified and sequenced the arp1 gene from genomic DNA of both mutant alleles. In one allele, were unable to identify a sequence change in the other mutant allele, arp1 2 , it maps by recombination in the same region of chromosome three as arp1 1 and fails to complement the arp1 1 mutant and deficiencies in this region of chromosome three. Thus, we presume that this mutant affects a regulatory region whose sequence we have not delineated. Since both mutant alleles had similar phenotypes, we focused on the arp1 1 allele. To confirm that the arp1 1 larval phenotype is due to an axonal transport defect, we stained larval segmental nerves with antibodies to synaptic proteins such as cysteine string protein (csp). In wild-type larvae, this antibody stains axons uniformly ( Figure 1C ), whereas in arp1 1 mutant larvae, synaptic proteins accumulate in axons ( Figure 1D ). The presence of these accumulations, previously observed in other axonal transport mutants (Bowman et al., 2000) , confirms that axonal transport is disrupted in the arp1 mutants.
To ask whether dynactin is required for all dynein functions in Drosophila, we evaluated whether the consequences of loss of dynein and dynactin differ by comparing the phenotypes caused by loss of Arp1 to loss of DHC. Since both dynein and dynactin are thought to play essential roles at multiple stages in the cell cycle, we evaluated cell cycle defects in larval brains using BrdU incorporation, TUNEL staining, and by directly examining dividing neuroblasts stained with DAPI. Observation and quantitation revealed that while the exact frequencies of defects in arp1 and dhc mutants were not identical, they were similar in character (Table 1 and Supplementary Figure 1,2) . Similarly, failures in cell viability and oocyte determination evaluated in mitotic clone experiments were similar in arp1 and dhc mutants (Table 1 and Supplementary Figure 1 ,2). These data suggest that dynein requires the dynactin complex for all cellular and developmental functions that we were able to test. We note that arp1 mutant animals survive later in development than do p150 Glued mutants; this difference is likely due to different levels of maternal contribution of these two dynactin components.
To determine whether the arp1 1 mutation destabilizes other dynactin subunits, we probed Western blots of larval brain homogenates with antibodies to different subunits of dynein and dynactin ( Figure 1E ). Although the amounts of DHC and dynein intermediate chain were unchanged in the arp1 1 mutants compared to wildtype, the p150 Glued protein was virtually absent in the arp1 1 mutant. The level of the dynamitin subunit (p50) was also significantly reduced.
The observed reduction of the p150 Glued and p50 subunits suggests that the dynactin complex is disrupted in the arp1
dynactin subunit p50 appears in a peak at ~4S-8S, suggesting that the arp1 1 mutants cause complete disruption of the dynactin complex. The arp1 1 mutation leads to the disappearance of the Arp1 peak at 17S-, while a peak at ~8S due to cross-reaction of our antibody with actin is still visible ( Figure 1F , 2C and 2D and see Materials and Methods).
To confirm and extend these observations, we used a Drosophila S2 cell culture system. S2 cells were grown in the presence of arp1 dsRNA or a GFP dsRNA as a negative control. Soluble (HSS) and membrane (HSP) fractions were analyzed by western blotting. As observed in brains of arp1 1 mutant larvae, reduction of Arp1 mRNA ( Figure 2B ) and protein levels ( Figure 2A) induces substantial reductions in the protein levels of both p150 Glued and p50, while the levels of DHC and kinesin heavy chain (KHC) remain unchanged. We then performed sucrose density gradient analyses. To detect p50 and p150 Glued in the arp1 dsRNA treated samples, longer exposure times were required. In both the soluble and membrane fractions, arp1 dsRNA treatment caused p50 and p150 Glued subunits to shift from ~17S to ~8S, while DHC and KHC remained unchanged, peaking at 17S and 8S, respectively, in both conditions (Figure 2 C-F). In the control, GFP dsRNA sample, the soluble dynactin subunits did not completely overlap in one single peak, while the membrane associated dynactin subunits displayed partial co-fractionation such that ARP1 primarily co-fractionates with DHC, and p150 Glued primarily co-fractionates with p50. Why the two sets of proteins have slightly different sedimentation profiles is unclear and might be caused by the stringency of the experimental conditions used or from a previously unsuspected instability of the soluble dynactin pool in S2 cells. Importantly however, loss of Arp1 causes a clear disruption of the dynactin complex, such that the fractions that do contain DHC do not overlap with fractions containing dynactin subunits. Thus, similar to dynamitin over-expression (Echeverri et al., 1996) (Eckley et al., 1999) , our results show that Arp1 mutation or deletion leads to disruption of the dynactin complex, in addition to reduction in the levels of both p150 Glued and p50. Our results also suggest that the membrane-associated dynactin complex is more stable than the soluble dynactin complex in S2 cells.
To test the hypothesis that dynactin is required to enhance the processivity of dynein, we investigated the effects of loss of Arp1 function on in vivo vesicle and organelle motility. We took advantage of the Gal4/UAS system to induce expression of a vesicular or a mitochondrial protein fused to YFP and GFP respectively. For vesicles, we studied axonal transport of the vesicular Amyloid Precursor Protein (APP) fused to YFP (Kaether et al., 2000 ) (Gunawardena et al., 2003) using the P(Gal4)SG26.1 driver line, which is only expressed in a few motor neurons in the segmental nerves of third instar larvae, allowing us to observe movements clearly. For mitochondria, we used a fusion of the leader peptide of human cytochrome C oxidase subunit 8
to GFP to target GFP to mitochondria (Horiuchi et al., 2005 ) (Pilling et al., 2006) and used the P(GawB)D42 driver line, which is expressed in all motor neurons. If dynactin has a role in enhancing the processivity of dynein, we expected that in an arp1 mutant background, APP containing vesicles and mitochondria would move towards the cell body with shorter runs and more frequent pauses. In control animals, kymograph analysis revealed many movements of fluorescent APP particles toward and away from the cell body ( Figure 3A ), suggesting that these vesicles are powered by both anterograde and retrograde motors. In the arp1 1 mutant, however, we observed significant numbers of stationary particles and organelle accumulations ( Figure 3B , 3C and Supplementary Figure 3B ,C), as we had seen previously with immunofluorescence studies ( Figure 1D) . Surprisingly, we saw very little movement of APP particles in either direction in the axons, even in regions where no organelle accumulations were present ( Figure   3D ). In almost half of the axons studied (16 of 33 movies, see Materials and Methods), axons showed no directed movements of APP vesicles; in fact, we frequently observed that many particles, especially within accumulations, underwent apparent Brownian motion indicative of motor detachment from microtubules.
To quantify in vivo motor function in the remaining axons that did display limited particle motion (17 movies), we evaluated four parameters: net velocity, segment velocity, pause frequency, and reversal frequency. Net velocity was defined as the net distance traveled by a particle divided by the time elapsed during an entire movie. Segment velocity was defined as the distance traveled by a particle during a run (i.e. unbroken by a pause, reversal, or end of a movie) divided by the time elapsed during that run. Run lengths were not explicitly reported due to inaccuracies resulting from runs already underway at the beginning of a movie, or prematurely terminated at the end of a movie. Rather, given the implicit correlation between shortened run lengths and increased likelihood of pausing, we used pause frequency, defined as the number of pauses occurring per μm of particle movement, as an indirect measure of processivity (see Materials and Methods) . Reversals were indicated by a sustained change in direction of motion for at least one second.
The moving particles in the arp1 1 mutant animals had a much slower segment velocities than in wild type and traveled shorter distances (i.e., displayed slower net velocities) ( Figure   3E ,F,G). Processivity was also affected in both directions, as there was an increased number of pauses per μm traveled in arp1 axons compared to wild type ( Figure 3H ). Estimating run lengths revealed that only 5% of anterograde runs in the arp1 1 mutant animals were longer than 13μm while fully 40% of anterograde runs in wild-type were longer than 13μm and 18% were 25μm or greater. Retrograde runs had similar behavior; only 3% of retrograde runs in the arp1 1 mutant animals were longer than 13μm while fully 40% of retrograde runs in wild-type were longer than 13μm and 5% were 25μm or greater. No retrograde runs in the arp1 1 mutant animals were longer than 19μm while 11% of retrograde runs in wild-type were longer than 19μm. These quantitative analyses suggest that the slower net velocities in both anterograde and retrograde particle pools are a result of both slower segment velocities as well as increased pause frequency.
( Figure 3B,C,D,H) . Our analysis of a limited number of particle reversals indicates a trend towards increased reversal from anterograde to retrograde movement in arp1 1 mutant axons, suggesting an additional role of dynactin in coordinating the activity of opposing motors on the same particle ( Figure 3I ).
Anterograde and retrograde mitochondrial movement was also reduced in the arp1 1 mutant compared to wildtype (Supplementary Figure 3D ,E). This is in contrast with the recent observation that a dominant negative allele of p150 Glued showed an increase in anterograde and retrograde movement of mitochondria (Pilling et al., 2006) . Thus, while our biochemical analyses demonstrate that arp1 1 mutations lead to disruption of the dynactin complex, heterozygous expression of a dominant negative allele of p150 Glued must retain sufficient function for mitochondrial transport (McGrail et al., 1995) .
A trivial cause of the lack of particle movement within the axons of arp1 1 mutant larvae could be that arp1 1 mutant neurons or animals are sick or dying. Two observations argue, however, that the motility defects observed are specifically caused by loss of dynactin function on vesicles or organelles. First, in previous work we found that intentionally inducing neuronal cell death did not cause defects in vesicle transport (Gunawardena et al., 2003) . Second, we observed that arp1 1 mutant siblings that were not dissected for live imaging survived at least another 48 hours. Thus, though we cannot fully exclude the possibility of transport defects secondary to global neuronal toxicity, it appears likely that the loss of a functional dynactin complex has a direct effect on organelle processivity and motility.
To test directly whether dynactin is required to link dynein to membranous organelles we examined the amount of membrane-bound dynein in arp1 1 mutant animals and in arp1 dsRNAtreated S2 cells. We performed subcellular fractionation of larval brains or S2 cell extracts by membrane floatation on sucrose step gradients ( Figure 4A ). We observed no significant difference in the amount of dynein that was associated with the membranes enriched in the 35/8 sucrose interface in wild type compared to the arp1 1 mutant brains ( Figure 4B ).
Membrane-associated proteins such as syntaxin were mainly present in the membrane fraction and not in the soluble pool, as expected. To confirm and extend these observations, we also analyzed membrane fractions prepared from arp1 dsRNA treated S2 cells. As reported in Figure   2A , and similar to what we saw with larval brains, we found that the levels of both p50 and p150 Glued are substantially reduced in membrane fractions in the 35/8 sucrose interface from the arp1 dsRNA treated S2 cells ( Figure 4C ). Although the overall levels of membrane associated DHC are lower in S2 cells than in larval brains, we consistently found that in both control and arp1 dsRNA treated cells, equivalent amounts of DHC are associated with membrane fractions enriched in Golgi and mitochondria. This result confirms the observation that in arp1 dsRNA treated S2 cells, the amount of dynein associated with a membrane fraction prepared by high speed centrifugation is not altered (Figure 2A ). Our results thus suggest that recruitment of dynein to membranous organelles, including Golgi and mitochondria enriched fractions, is independent of an intact dynactin complex It is possible however that smaller amounts of a disrupted dynactin complex on membranous compartment is sufficient to recruit DHC. In this regard, it is worth noting that the membrane-associated pool of p50 partially co-fractionates with DHC in the absence of p150 Glued and Arp1 ( Figure 2F ). While DHC might be recruited onto membranes by binding to a p50 subcomplex, this binding might not be efficient as suggested by our analyses of moving vesicles and organelles.
Our results suggest that an intact dynactin complex is not required for dynein to bind to membranous compartments. This proposal is supported by previous work suggesting that dynein subunits can interact directly with different types of cargo proteins (Almenar-Queralt and Goldstein, 2001). Our finding that arp1 mutants exhibit numerous phenotypic defects that are similar to dynein mutants, as well as obvious defects in minus-end directed movements, is consistent with the proposal that dynactin plays an important role in regulating the processivity, or other aspects, of dynein motility (King and Schroer, 2000) . However, even though we see apparently unchanged amounts of dynein binding to membranes when dynactin is disrupted, it is formally possible that the mode of attachment of dynein to cargo influences the characteristics of motility. For example, altered dynactin complex behavior resulting from Arp1 reduction on moving vesicles and organelles might cause incorrect attachment of DHC to membranous organelles, without affecting processivity per se. Similarly, the increased number of stationary organelles observed after Arp1 reduction could be explained by the direct association of dynein with membranes in a non-physiological manner. The observed decrease in retrograde velocity may also reflect abnormal attachment of the dynein complex to membranes. Alternatively, given that dynein is a cooperative motor, this decrease in velocity may also be a result of poor coordination among dynein complexes attached to a given cargo. We are unable to distinguish between these scenarios based on our data thus far.
Our observation that the arp1 1 mutant also disrupts anterograde movement of APP containing vesicles and mitochondria does not easily fit the proposal that dynactin's regulatory function is restricted to the processivity of dynein. Interestingly, depletion of Arp1 may have reduced the levels of KHC on membranes ( Figure 4C ). Although the degree of reduction is small, it may suggest how dynactin functions in anterograde movement. Whether dynactin in fact plays a direct role in kinesin recruitment to membranes will require further investigation.
Nonetheless, our data are consistent with an additional role for dynactin in regulating anterograde motors such as kinesin, or as recently proposed, a role in coordinating plus and minus-end directed transport (Gross et al., 2002b ) (Gross et al., 2000 ) (Gross et al., 2002a) . In particular, a dominant mutation in p150 Glued severely impaired "anterograde" motion of lipid droplets in Drosophila embryos. Similarly, disruption of dynactin by overexpressing dynamitin inhibited movement of endosomes in both directions (Valetti et al., 1999) . Finally, biochemical support for a role of dynactin in coordinating plus and minus end directed movements comes from the finding that a subunit of kinesin II can interact with p150 Glued (Deacon et al., 2003) , and that dynein interacts directly with kinesin light chain (Ligon et al., 2004) . Thus, our data, combined with earlier work, suggests that the in vivo function of dynactin is to regulate and/or coordinate bidirectional motility, but that dynactin may not be required to link dynein to membranes. The p150 Glued and p50 subunits are obviously reduced in the arp1 mutant larvae. (F) The dynactin complex is disrupted in the arp1 1 mutant. Third instar larval brains were homogenized and a high speed supernatant was sedimented on a 5%-20% sucrose gradients. In wild type, sedimentation of the dynactin subunits peaks at ~17S-, whereas in the arp1 1 mutant, both Arp1
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and p50 sediment at ~4S-8S. Asterisk (*) points to dynamitin in the Arp1 blot (the same blot has been reprobed). The peak of Arp1 reactivity detected at ~4S in addition to the expected peak at 17S is due to cross reactivity of our Arp1 antibody with actin (see Materials and Methods and Figure 2 ).
Figure 2
The dynactin complex, but not dynein, is disrupted in the arp1 dsRNA treated cells. RNAi treated samples were compared to the GFP RNAi treated samples and normalized to GAPDH. Knock-down of arp1 transcript is shown in percent (mean of 3 experiments +/-SEM).
(C-F) HSS and HSP from arp1 dsRNA and GFP dsRNA treated cells were sedimented on a 5%-20% sucrose gradients. In GFP dsRNA treated cells, sedimentation of the dynactin subunits Arp1, p150 Glued and p50 are found in a broad peak at ~17, whereas in the arp1 dsRNA treated cells, Arp1 levels are reduced and both p150 Glued and p50 are found at ~8S. Note that in the arp1 dsRNAtreated samples, the levels of p50 and p150 Glued are reduced and western blots for p50 and p150 Glued required longer exposure times in 2D and 2F (see brackets and 2A). The Arp1 band detected at ~8S in both GFP and arp1 dsRNA HSS corresponds to the actin-cross reactivity.
This band is not observed in the HSP fraction where no actin can be detected. Dynein and kinesin sedimentation properties are not affected by reduction of Arp1, peaking at ~17S and ~8S, respectively. In C and D, arrowhead points to the 400kd dynein heavy chain. FRT sequence and a dominant female-sterile mutation, ovoD 1 , which prevents the female germ line from developing at all (Golic 1991 , Golic and Lindquist 1989 , Chou and Perrimon, 1996 .
Following heat-induced expression of FLP recombinase, any developing oocyte must have arisen from a mitotic recombination event that produced a stem cell that lost ovo D1 , and is now homozygous for the arp1 1 mutant. Mosaic egg chambers that lack arp1 function in the germ line
